Literature DB >> 10682656

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

R I Nicholson1, J M Gee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10682656      PMCID： PMC2363333          DOI： 10.1054/bjoc.1999.0954

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  208 in total

Review 1.  Prognostic factors in breast cancer.

Authors:  D E Merkel; C K Osborne
Journal:  Hematol Oncol Clin North Am       Date:  1989-12       Impact factor: 3.722

2.  Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast.

Authors:  E P Sandgren; N C Luetteke; R D Palmiter; R L Brinster; D C Lee
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

Authors:  C L Arteaga; C K Osborne
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

4.  Activity of pp60c-src protein kinase in human breast cancer.

Authors:  S Lehrer; J O'Shaughnessy; H K Song; E Levine; P Savoretti; J Dalton; R Lipsztein; S Kalnicki; W D Bloomer
Journal:  Mt Sinai J Med       Date:  1989-03

5.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

6.  Strong association between c-myb and oestrogen-receptor expression in human breast cancer.

Authors:  M Guérin; Z M Sheng; N Andrieu; G Riou
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

7.  Modulation of human breast cancer cell adhesion by estrogens and antiestrogens.

Authors:  R Millon; F Nicora; D Muller; M Eber; C Klein-Soyer; J Abecassis
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

8.  Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy.

Authors:  J F Robertson; M R Williams; J Todd; R I Nicholson; D A Morgan; R W Blamey
Journal:  Eur J Cancer Clin Oncol       Date:  1989-03

9.  Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.

Authors:  V Castronovo; G Taraboletti; L A Liotta; M E Sobel
Journal:  J Natl Cancer Inst       Date:  1989-05-10       Impact factor: 13.506

10.  Ki67 immunostaining in primary breast cancer: pathological and clinical associations.

Authors:  N Bouzubar; K J Walker; K Griffiths; I O Ellis; C W Elston; J F Robertson; R W Blamey; R I Nicholson
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640
View more
  11 in total

Review 1.  Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.

Authors:  R I Nicholson; I R Hutcheson; H E Jones; S E Hiscox; M Giles; K M Taylor; J M W Gee
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

Review 2.  Targeting the insulin growth factor receptor 1.

Authors:  Fernanda I Arnaldez; Lee J Helman
Journal:  Hematol Oncol Clin North Am       Date:  2012-02-28       Impact factor: 3.722

Review 3.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.

Authors:  Stephanie L Nott; Yanfang Huang; Aja Kalkanoglu; Kathryn Harper; Ming Chen; Scott F Paoni; Bruce M Fenton; Mesut Muyan
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

5.  Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

Authors:  Francesca De Amicis; Janagi Thirugnansampanthan; Yukun Cui; Jennifer Selever; Amanda Beyer; Irma Parra; Nancy L Weigel; Matthew H Herynk; Anna Tsimelzon; Michael T Lewis; Gary C Chamness; Susan G Hilsenbeck; Sebastiano Andò; Suzanne A W Fuqua
Journal:  Breast Cancer Res Treat       Date:  2009-06-17       Impact factor: 4.872

Review 6.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

7.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

8.  Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.

Authors:  Wei Yue; Ping Fan; Jiping Wang; Yuebai Li; Richard J Santen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

9.  GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.

Authors:  Tesfom Abrhale; Angela Brodie; Gauri Sabnis; Luciana Macedo; Changsheng Tian; Binbin Yue; Ginette Serrero
Journal:  BMC Cancer       Date:  2011-06-09       Impact factor: 4.430

10.  Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer.

Authors:  Noriko Yoshimura; Nobuhiro Harada; Ida Bukholm; Rolf Kåresen; Anne-Lise Børresen-Dale; Vessela N Kristensen
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.